Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Improving engraftment of hepatocyte transplantation using alpha-1 antitrypsin as an immune modulator.

Lee C, Dhawan A, Iansante V, Filippi C, Mitry R, Tang J, Walker S, Fernandez DaCosta R, Sinha S, Hughes RD, Koulmanda M, Fitzpatrick E.

J Mol Med (Berl). 2019 Feb 28. doi: 10.1007/s00109-019-01747-3. [Epub ahead of print]

PMID:
30820592
2.

Dynamin-1-Like Protein Inhibition Drives Megamitochondria Formation as an Adaptive Response in Alcohol-Induced Hepatotoxicity.

Palma E, Ma X, Riva A, Iansante V, Dhawan A, Wang S, Ni HM, Sesaki H, Williams R, Ding WX, Chokshi S.

Am J Pathol. 2019 Mar;189(3):580-589. doi: 10.1016/j.ajpath.2018.11.008. Epub 2018 Dec 14.

PMID:
30553835
3.

A New High Throughput Screening Platform for Cell Encapsulation in Alginate Hydrogel Shows Improved Hepatocyte Functions by Mesenchymal Stromal Cells Co-encapsulation.

Iansante V, Dhawan A, Masmoudi F, Lee CA, Fernandez-Dacosta R, Walker S, Fitzpatrick E, Mitry RR, Filippi C.

Front Med (Lausanne). 2018 Aug 9;5:216. doi: 10.3389/fmed.2018.00216. eCollection 2018.

4.

Cell-based liver therapies: past, present and future.

Iansante V, Chandrashekran A, Dhawan A.

Philos Trans R Soc Lond B Biol Sci. 2018 Jul 5;373(1750). pii: 20170229. doi: 10.1098/rstb.2017.0229. Review.

PMID:
29786563
5.

Cryopreserved neonatal hepatocytes may be a source for transplantation: Evaluation of functionality toward clinical use.

Lee CA, Dhawan A, Iansante V, Lehec S, Khorsandi SE, Filippi C, Walker S, Fernandez-Dacosta R, Heaton N, Bansal S, Mitry RR, Fitzpatrick E.

Liver Transpl. 2018 Mar;24(3):394-406. doi: 10.1002/lt.25015.

6.

Human hepatocyte transplantation for liver disease: current status and future perspectives.

Iansante V, Mitry RR, Filippi C, Fitzpatrick E, Dhawan A.

Pediatr Res. 2018 Jan;83(1-2):232-240. doi: 10.1038/pr.2017.284. Epub 2017 Dec 6. Review.

PMID:
29149103
7.

Alginate Encapsulation of Human Hepatocytes and Assessment of Microbeads.

Mitry RR, Jitraruch S, Iansante V, Dhawan A.

Methods Mol Biol. 2017;1506:273-281.

PMID:
27830560
8.

PARP14 promotes the Warburg effect in hepatocellular carcinoma by inhibiting JNK1-dependent PKM2 phosphorylation and activation.

Iansante V, Choy PM, Fung SW, Liu Y, Chai JG, Dyson J, Del Rio A, D'Santos C, Williams R, Chokshi S, Anders RA, Bubici C, Papa S.

Nat Commun. 2015 Aug 10;6:7882. doi: 10.1038/ncomms8882.

9.

Poly(ADP-ribose) polymerase family member 14 (PARP14) is a novel effector of the JNK2-dependent pro-survival signal in multiple myeloma.

Barbarulo A, Iansante V, Chaidos A, Naresh K, Rahemtulla A, Franzoso G, Karadimitris A, Haskard DO, Papa S, Bubici C.

Oncogene. 2013 Sep 5;32(36):4231-42. doi: 10.1038/onc.2012.448. Epub 2012 Oct 8.

10.

The glycosaminoglycan-binding domain of PRELP acts as a cell type-specific NF-kappaB inhibitor that impairs osteoclastogenesis.

Rucci N, Rufo A, Alamanou M, Capulli M, Del Fattore A, Ahrman E, Capece D, Iansante V, Zazzeroni F, Alesse E, HeinegÄrd D, Teti A.

J Cell Biol. 2009 Nov 30;187(5):669-83. doi: 10.1083/jcb.200906014.

Supplemental Content

Loading ...
Support Center